References
- Boschiroli ML, Foulongne V, O'Callaghan D. Brucellosis: a world wide zoonosis. Curr Opin Microbiol 2001; 4: 58–64
- Cooke GS, Hill AVS. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001; 2: 967–77
- Mustelin T, Vang T, Botín N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 2005; 5: 43–57
- Andersen JN, Cansen PG, Echwald SM, Mortensen OH, Fukada T, del Vecchio R, et al. A genomic perspective on protein tyrosine phosphatases gene structure, pseudogenes, and genetic disease linkage. FASEB J 2004; 18: 8–30
- Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999; 93: 2013–24
- Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signalling by a complex between a kinase and a phosphatase. J Exp Med 1999; 189: 111–21
- Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 2004; 36: 337–8
- Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004; 75: 330–7
- Orozco G, Sánchez E, González-Gay MA, López-Nevot MA, Torres B, Cáliz R, et al. Association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005; 52: 219–24
- Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J Clin Endocrinol Metab 2004; 89: 5862–5
- Vang T, Congia M, Macis MD, Musumeci L, Orru V, Zavattari P, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005; 37: 1317–9
- Moyer N, Holcomb LA. Brucella. Manual of clinical microbiology6th edn, PR Murray, EJ Baron, MA Pfaller, FC Tanover, RH Yolken. American Society for Microbiology, Washington, DC 1995; 382–6
- Alton GG, Jones LM, Pietz DE. Laboratory techniques in brucellosis. Monogr Ser World Health Organ 1975; 55: 1–163
- Orduña A, Almaraz A, Prado A, Gutierrez MP, García-Pascual A, Dueñas A, et al. Evaluation of an immunocapture-agglutination test (Brucellacapt) for the serodiagnosis of human brucellosis. J Clin Microbiol 2000; 38: 4000–5
- Bravo MJ, de Dios Colmenero J, Alonso A, Caballero A. Polymorphisms of the interferon gamma and interleukin 10 genes in human brucellosis. Eur J Immunogenet 2003; 30: 433–5
- Gjörloff-Wingren A, Saxena M, Williams S, Hammi D, Mustelin T. Characterization of TCR-induced receptor-proximal signalling events negatively regulated by the protein tyrosine phosphatises PEP. Eur J Immunol 1999; 29: 3845–54
- Lykouras D, Sampsonas F, Kaparianos A, Karkoulias K, Tsoukalas G, Spiropoulos K. Human genes in TB infection: their role in immune response. Monaldi Arch Chest Dis 2008; 69: 24–31
- Bravo MJ, Colmenero JD, Martin J, Alonso A, Caballero A. Polymorphism of the transmembrane region of the MICA gene and human brucellosis. Tissue Antigens 2007; 69: 358–60